These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanes. Graham TH; Liu W; Verras A; Reibarkh M; Bleasby K; Bhatt UR; Chen Q; Garcia-Calvo M; Geissler WM; Gorski JN; He H; Lassman ME; Lisnock J; Li X; Shen Z; Tong X; Tung EC; Wiltsie J; Xie D; Xu S; Xiao J; Hale JJ; Pinto S; Shen DM Bioorg Med Chem Lett; 2012 Apr; 22(8):2818-22. PubMed ID: 22444685 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of prolylcarboxypeptidase (PrCP) inhibitors to validate PrCP as a potential target for obesity. Zhou C; Garcia-Calvo M; Pinto S; Lombardo M; Feng Z; Bender K; Pryor KD; Bhatt UR; Chabin RM; Geissler WM; Shen Z; Tong X; Zhang Z; Wong KK; Roy RS; Chapman KT; Yang L; Xiong Y J Med Chem; 2010 Oct; 53(19):7251-63. PubMed ID: 20857914 [TBL] [Abstract][Full Text] [Related]
8. Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors. Debenham JS; Graham TH; Verras A; Zhang Y; Clements MJ; Kuethe JT; Madsen-Duggan C; Liu W; Bhatt UR; Chen D; Chen Q; Garcia-Calvo M; Geissler WM; He H; Li X; Lisnock J; Shen Z; Tong X; Tung EC; Wiltsie J; Xu S; Hale JJ; Pinto S; Shen DM Bioorg Med Chem Lett; 2013 Dec; 23(23):6228-33. PubMed ID: 24157366 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanine. Wu Z; Yang C; Xiong Y; Feng Z; Lombardo M; Verras A; Chabin RM; Xu S; Tong X; Xie D; Lassman ME; Bhatt UR; Garcia-Calvo MM; Geissler W; Shen Z; Chen Q; Sinharoy R; Hale JJ; Tata JR; Pinto S; Shen DM; Colletti SL Bioorg Med Chem Lett; 2012 Feb; 22(4):1774-8. PubMed ID: 22248857 [TBL] [Abstract][Full Text] [Related]
10. Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity. He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Bakshi RK; Dellureficio JP; Hong Q; Weinberg DH; Macneil T; Tang R; Strack AM; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Fong TM; Wyvratt MJ; Nargund RP Bioorg Med Chem Lett; 2010 Aug; 20(15):4399-405. PubMed ID: 20598882 [TBL] [Abstract][Full Text] [Related]
11. Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk). Moriarty KJ; Takahashi H; Pullen SS; Khine HH; Sallati RH; Raymond EL; Woska JR; Jeanfavre DD; Roth GP; Winters MP; Qiao L; Ryan D; DesJarlais R; Robinson D; Wilson M; Bobko M; Cook BN; Lo HY; Nemoto PA; Kashem MA; Wolak JP; White A; Magolda RL; Tomczuk B Bioorg Med Chem Lett; 2008 Oct; 18(20):5545-9. PubMed ID: 18819799 [TBL] [Abstract][Full Text] [Related]
12. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431 [TBL] [Abstract][Full Text] [Related]
13. Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis. Rabey FM; Gadepalli RS; Diano S; Cheng Q; Tabrizian T; Gailani D; Rimoldi JM; Shariat-Madar Z Curr Med Chem; 2012; 19(24):4194-206. PubMed ID: 22664251 [TBL] [Abstract][Full Text] [Related]